ritonavir
Generic: ritonavir
Labeler: nucare pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
ritonavir
Generic Name
ritonavir
Labeler
nucare pharmaceuticals, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
ritonavir 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68071-3898
Product ID
68071-3898_3f92f1e9-d808-9820-e063-6394a90aa98b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA206614
Listing Expiration
2026-12-31
Marketing Start
2018-09-17
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
680713898
Hyphenated Format
68071-3898
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ritonavir (source: ndc)
Generic Name
ritonavir (source: ndc)
Application Number
ANDA206614 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 3 TABLET, FILM COATED in 1 BOTTLE (68071-3898-3)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3f92f1e9-d808-9820-e063-6394a90aa98b", "openfda": {"nui": ["N0000000246", "N0000191001", "N0000175889", "N0000190114", "N0000182137", "N0000185607", "N0000190118", "N0000185503", "N0000190113", "N0000182141", "N0000191266", "N0000185507", "N0000187064", "N0000190117"], "upc": ["0368071389838"], "unii": ["O3J8G9O825"], "rxcui": ["900575"], "spl_set_id": ["3f92f1e2-59f4-f6c4-e063-6294a90a487b"], "pharm_class_epc": ["Cytochrome P450 3A Inhibitor [EPC]", "Protease Inhibitor [EPC]"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "UDP Glucuronosyltransferases Inducers [MoA]"], "manufacturer_name": ["NuCare Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "3 TABLET, FILM COATED in 1 BOTTLE (68071-3898-3)", "package_ndc": "68071-3898-3", "marketing_start_date": "20250924"}], "brand_name": "Ritonavir", "product_id": "68071-3898_3f92f1e9-d808-9820-e063-6394a90aa98b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 3A Inhibitor [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inducers [MoA]"], "product_ndc": "68071-3898", "generic_name": "Ritonavir", "labeler_name": "NuCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ritonavir", "active_ingredients": [{"name": "RITONAVIR", "strength": "100 mg/1"}], "application_number": "ANDA206614", "marketing_category": "ANDA", "marketing_start_date": "20180917", "listing_expiration_date": "20261231"}